Cas 910544-76-2,2(R)-(2,2,3,3,3-pentafluoropropylamino)-3-tritylsulfanylpropionic acid

910544-76-2

Post Buying Request

Basic information

Product Name: 2(R)-(2,2,3,3,3-pentafluoropropylamino)-3-tritylsulfanylpropionic acid
Synonyms: 2(R)-(2,2,3,3,3-pentafluoropropylamino)-3-tritylsulfanylpropionic acid
CAS NO:910544-76-2
Molecular Formula:
Molecular Weight: 495.513
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2(R)-(2,2,3,3,3-pentafluoropropylamino)-3-tritylsulfanylpropionic acid(CAS DataBase Reference)
NIST Chemistry Reference: 2(R)-(2,2,3,3,3-pentafluoropropylamino)-3-tritylsulfanylpropionic acid(910544-76-2)
EPA Substance Registry System: 2(R)-(2,2,3,3,3-pentafluoropropylamino)-3-tritylsulfanylpropionic acid(910544-76-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 910544-76-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

910544-76-2 Suppliers

Recommended suppliers

910544-76-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 910544-76-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,0,5,4 and 4 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 910544-76:
(8*9)+(7*1)+(6*0)+(5*5)+(4*4)+(3*4)+(2*7)+(1*6)=152
152 % 10 = 2
So 910544-76-2 is a valid CAS Registry Number.

910544-76-2Upstream product

2799-07-7 (S)-trityl-D-cysteine

910544-76-2Downstream Products

910544-76-2Relevant academic research and scientific papers

ALPHA KETOAMIDE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

-

Page/Page column 66; 69, (2008/06/13)

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 910544-76-2